New Role for Olaparib in BRCA Ovarian Cancer in Neoadjuvant Setting New Role for Olaparib in BRCA Ovarian Cancer in Neoadjuvant Setting

Administering olaparib in the neoadjuvant setting resulted in favorable surgical options, manageable adverse events, and positive health outcomes in women with ovarian cancer and germline mutations.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news